The company will market and distribute Algatech's proprietary AstaPure astaxanthin in the form of vegan beadlets.
Photo © iStockphoto.com/RapidEye
Lycored (Secaucus, NJ) has announced a joint venture with astaxanthin supplier Algatechnologies (Ketura, Israel). The company will market and distribute Algatech's proprietary AstaPure natural astaxanthin in the North American market in the form of vegan beadlets.
In beadlet form, the astaxanthin can be used in both dietary supplements and in food and beverages, says Lycored, including dry blended beverages and nutrition bars. Algatechnologies CEO Hagai Stadler says, “Lycored’s microencapsulation technology…is the right partner for Algatechnologies and will contribute significantly to the development of the astaxanthin market.”
Lycored, which has primarily specialized in the carotenoid lycopene, is extending its reach into astaxanthin. The company recently patented a combination of lycopene and astaxanthin with anti-inflammatory benefits.
Algatechnologies derives its AstaPure astaxanthin from Haematococcus pluvialis algae. Golan Raz, Lycored’s head of Global Health Division, says that Lycored will have “complete access and transparency” of Algatechnologies’ supply chain. Raz adds, “Lycored wanted to evolve its astaxanthin offerings while maintaining our commitment to distributing premium-quality ingredients that consumers and industry partners can trust. We are able to maintain vertical integration through this partnership as it is the process Algatech takes when developing their astaxanthin ingredient.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.